Latest Product Launch News

Breville Group delivered record FY26 revenue of AUD 1.81 billion and EBIT of AUD 207 million, navigating tariff volatility and currency headwinds while completing a major manufacturing diversification.

GWA Group posted modest revenue and earnings growth in FY26, driven by volume gains across Australia, New Zealand, and the UK, while raising dividends and advancing strategic priorities despite challenging market conditions.

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

Cadence Opportunities Fund fell 2.3% in July, lagging the All Ordinaries index, but delivered a robust 26.6% gain over the past year and declared fully franked dividends yielding up to 7.4%.

Ainsworth Game Technology has locked in a critical patent licence agreement with Aristocrat, granting rights to key gaming features and responsible gaming technologies in Australia while settling past patent disputes.

Ovanti Limited is raising up to A$2.293 million through a 1-for-1 entitlement offer priced at $0.002 per share, marking a significant capital boost at a notable discount to recent trading.

SportsHero Limited has inked a deal with Razer to offer over 1,000 gaming-related digital products via its HeroPlay platform, broadening its reach beyond mobile subscriptions into consoles and PCs across Southeast Asia.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

Galan Lithium is set to become a significant lithium brine producer with its Hombre Muerto West project in Argentina, targeting first sales in the second half of 2026. The company boasts a world-class resource, strong fiscal incentives, and a valuation discount to ASX peers.

Atomos Limited has turned a corner in FY26, posting over 20% sales growth to around $40 million and swinging to EBITDA profitability after prior losses, boosted by new product launches and the strategic acquisition of Flanders Scientific.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.